Literature DB >> 12403950

'Footprints' of transient ischemic attacks: a diffusion-weighted MRI study.

Hakan Ay1, Jamary Oliveira-Filho, Ferdinando S Buonanno, Pamela W Schaefer, Karen L Furie, Yuchiao Chang Chang, Guy Rordorf, Lee H Schwamm, R Gilberto Gonzalez, Walter J Koroshetz.   

Abstract

OBJECTIVE: Diffusion-weighted imaging (DWI) conveys temporal as well as anatomic information about brain infarction, and is therefore well suited to identify ischemic injury that has occurred simultaneously, or closely linked in time, with a transient ischemic attack (TIA). We aimed to determine the proportion and clinical characteristics of patients with TIA who harbor infarction(s) on DWI.
METHODS: Using T(2)-weighted imaging (T(2)-WI), fast fluid attenuated inversion recovery (FLAIR), and DWI, we studied 57 consecutive patients presenting with acute focal neurologic symptoms lasting less than 24 h.
RESULTS: A hyperintense DWI lesion was identified in a vascular territory appropriate to the symptoms in 27 patients (47%). Lesions judged to be clinically appropriate on T(2)-WI and FLAIR overlapped with a DWI lesion in 41 and 48% of patients, respectively. Independent predictors of infarction on DWI were previous nonstereotypic TIAs, presentation with motor symptoms, and identified stroke mechanism.
CONCLUSION: DWI establishes that recent infarction occurs in almost half of patients with the clinical syndrome of TIA and this subgroup is more likely to harbor an underlying cardiac or cerebrovascular abnormality. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12403950     DOI: 10.1159/000065682

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  27 in total

1.  Transient ischemic attack: are there different types or classes? Risk of stroke and treatment options.

Authors:  Hakan Ay; Walter J Koroshetz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

2.  Diffusion-weighted MR imaging in transient ischaemic attacks.

Authors:  C Lamy; C Oppenheim; D Calvet; V Domigo; O Naggara; J L Méder; J L Mas
Journal:  Eur Radiol       Date:  2006-01-05       Impact factor: 5.315

3.  The use of neurovascular imaging for triaging TIA and minor stroke: implications for therapy.

Authors:  Andrew M Demchuk
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

4.  Do transient ischemic attacks with diffusion-weighted imaging abnormalities correspond to brain infarctions?

Authors:  C Oppenheim; C Lamy; E Touzé; D Calvet; M Hamon; J-L Mas; J-F Méder
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

5.  "Mechanism of multiple infarcts in multiple cerebral circulations on diffusion weighted imaging" by Cho et al.

Authors:  Achim Gass
Journal:  J Neurol       Date:  2007-06-23       Impact factor: 4.849

Review 6.  Imaging of the brain and cerebral vasculature in patients with suspected stroke: advantages and disadvantages of CT and MRI.

Authors:  Chelsea S Kidwell; Amie W Hsia
Journal:  Curr Neurol Neurosci Rep       Date:  2006-01       Impact factor: 5.081

7.  [European Stroke Organisation 2008 guidelines for managing acute cerebral infarction or transient ischemic attack. Part 1].

Authors:  P Ringleb; P D Schellinger; W Hacke
Journal:  Nervenarzt       Date:  2008-08       Impact factor: 1.214

8.  Multimodal imaging in acute ischemic stroke.

Authors:  William A Copen
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-03

9.  Frequency of emerging positive diffusion-weighted imaging in early repeat examinations at least 24 h after transient ischemic attacks.

Authors:  Naomi Morita; Masafumi Harada; Junichiro Satomi; Yuka Terasawa; Ryuji Kaji; Shinji Nagahiro
Journal:  Neuroradiology       Date:  2012-11-16       Impact factor: 2.804

10.  A score to predict early risk of recurrence after ischemic stroke.

Authors:  H Ay; L Gungor; E M Arsava; J Rosand; M Vangel; T Benner; L H Schwamm; K L Furie; W J Koroshetz; A G Sorensen
Journal:  Neurology       Date:  2009-12-16       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.